This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Using credit card rewards wisely can lead to significant benefits. Explore various ways to make the most of your rewards.
19,889 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Finance Of America has closed an all-cash acquisition of Onity’s reverse mortgage servicing rights, adding roughly 20...
A veteran portfolio manager says the real crowded trade is hiding in plain sight, far from the Mag 7 narrative. He po...
Ripple (XRP) is facing a critical test near the $1 threshold as ETF flows turn mixed and on-chain signals flicker. Tr...
Cadence Design Systems posted a strong Q1 FY2026, underscoring a rising demand for AI chip design tools. A record bac...
June 2026 looked like a milestone month for Oklo, but the stock went the other way. This deep dive explains why the s...
Russia’s largest bank Sber plans to launch a crypto wallet and digital depository inside its app by early December, c...
Broadcom stock rose on news of a strategic partnership update disclosed in a regulatory filing. This article breaks d...
OpenAI pursues a bold $1 trillion valuation as investors weigh hype against real-world profitability and a widening l...
Smart money is moving away from Algarve retirement hotspots toward Portugal's Silver Coast and inland towns, reshapin...
The latest Planning & Progress Study shows the magic number to retire comfortably climbed to $1.46 million, up 15% ye...
A 62-year-old with a $950,000 nest egg can retire in Minnesota and access premier healthcare. Success rests on timely...